Situational analysis of medical care for heart failure patients in a regional hospital in central Taiwan

Situational analysis of medical care for heart failure patients in a regional hospital in central Taiwan

Background: Heart failure (HF) is a complex clinical syndrome and a leading cause of morbidity and mortality worldwide. Its symptoms are the ultimate severe results of all heart diseases. Objectives: To assess the situation of medical care for patients with HF in a regional hospital in central Taiwa...

Full description

Bibliographic Details
Main Authors:	Yi-Chun Yang, Pin-Chun Lin, Chun-Hui Chiao, Cheng-Sheng Lin
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Tungs’ Medical Journal
Subjects:	guideline-directed medical therapy heart failure heart failure with reduced ejection fraction retrospective research
Online Access:	https://journals.lww.com/TMJ/Pages/default.aspx/article.asp?issn=2071-3592;year=2023;volume=17;issue=3;spage=38;epage=41;aulast=Yang

Similar Items

Interpretation of the Essential Updates in 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
by: Yifang GUO
Published: (2022-06-01)

Summary and Comparison of the 2022 ACC/AHA/HFSA and 2021 ESC Heart Failure Guidelines
by: Sarah Badger, et al.
Published: (2023-08-01)

Diabetic microvascular complications predicts non‐heart failure with reduced ejection fraction in type 2 diabetes
by: Mayu Tochiya, et al.
Published: (2023-04-01)

Heart failure with mid‐range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines
by: Luca Branca, et al.
Published: (2020-04-01)

Practical Recommendations for the Use of Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Heart Failure: Insights from Indian Cardiologists
by: Jamshed Dalal, et al.
Published: (2023-06-01)

Association of Depression and Anxiety with Cardiac Structural and Functional Characteristics in Heart Failure with Reduced and Mildly Reduced Ejection Fraction
by: Timea Magdolna Szabo, et al.
Published: (2023-03-01)

Expert opinion on the identification and pharmacological management of worsening heart failure: A consensus statement from India
by: Sandeep Seth, et al.
Published: (2023-01-01)

Cause of Death in Heart Failure Based on Etiology: Long-Term Cohort Study of All-Cause and Cardiovascular Mortality
by: Giosafat Spitaleri, et al.
Published: (2022-01-01)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
by: Chiara Borrelli, et al.
Published: (2019-09-01)

Metabolomics and a Breath Sensor Identify Acetone as a Biomarker for Heart Failure
by: Patrick A. Gladding, et al.
Published: (2022-12-01)

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
by: Kaiyuan Zhu, et al.
Published: (2021-07-01)

A comparison of clinical outcomes following atrial fibrillation ablation for heart failure patients with preserved or reduced left ventricular function: A systematic review and meta-analysis
by: Gaurav Panchal, et al.
Published: (2022-01-01)

Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
by: Tin‐Kwang Lin, et al.
Published: (2019-06-01)

Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis
by: Chao Ma, et al.

The Impact of Specialised Heart Failure Outpatient Care on the Long-Term Application of Guideline-Directed Medical Therapy and on Prognosis in Heart Failure with Reduced Ejection Fraction
by: Balázs Muk, et al.
Published: (2024-01-01)

Vericiguat: The Fifth Harmony of Heart Failure with Reduced Ejection Fraction
by: Luigi Falco, et al.
Published: (2023-09-01)

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
by: Marat Fudim, et al.
Published: (2021-11-01)

Predictors and Prognostic Value of Worsening Renal Function During Admission in HFpEF Versus HFrEF: Data From the KorAHF (Korean Acute Heart Failure) Registry
by: Jeehoon Kang, et al.
Published: (2018-03-01)

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
by: Valeria Conti, et al.
Published: (2020-11-01)

Coronary Artery Spasm-Related Heart Failure Syndrome: Literature Review
by: Ming-Jui Hung, et al.
Published: (2023-04-01)

Association of ambient temperature and acute heart failure with preserved and reduced ejection fraction
by: Takahiro Jimba, et al.
Published: (2022-10-01)

New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
by: I. V. Gribkova
Published: (2024-03-01)

Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction
by: Federico Ferro, et al.
Published: (2022-07-01)

Axial Muscle Size as a Strong Predictor of Death in Subjects With and Without Heart Failure
by: Anupam Kumar, et al.
Published: (2019-02-01)

Presentation, Management, and In-Hospital Outcomes of Patients with Acute Heart Failure in South India by Sex: A Secondary Analysis of a Prospective, Interrupted Time Series Study
by: Anubha Agarwal, et al.
Published: (2021-09-01)

Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication
by: Michael Lichtenauer, et al.
Published: (2021-05-01)

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study
by: Eiichi Akiyama, et al.
Published: (2020-06-01)

Effect of aggressive diuresis in acute heart failure with reduced and preserved ejection fraction
by: Xin He, et al.
Published: (2021-08-01)

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON‐HF trial
by: Lars H. Lund, et al.
Published: (2022-02-01)

Heart failure. The current state of the problem: achievements, frustrations, hopes and prospects
by: E. F. Pavlysh, et al.
Published: (2019-04-01)

Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction
by: Liam Gaziano, et al.
Published: (2021-12-01)

Sex differences in efficacy of pharmacological therapies in heart failure with reduced ejection fraction: a meta‐analysis
by: Cecilia Danielson, et al.
Published: (2022-08-01)

New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events
by: Carlo Lavalle, et al.
Published: (2023-11-01)

Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Palestine: Retrospective clinical audit study
by: Ammar Abdulrahman Jairoun, et al.
Published: (2024-03-01)

Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus
by: Alexander A. Berezin, et al.
Published: (2022-09-01)

Effectiveness and safety of transcatheter aortic valve replacement in elderly people with severe aortic stenosis with different types of heart failure
by: Mei Dong, et al.
Published: (2023-01-01)

Relationship Between Dietary Magnesium Intake and Incident Heart Failure Among Older Women: The WHI
by: Wen‐Chih Wu, et al.
Published: (2020-04-01)

Personalized Target Heart Rate for Patients with Heart Failure and Reduced Ejection Fraction
by: Yusuke Yumita, et al.
Published: (2022-01-01)

Rethinking heart failure clinical trials: the heart failure collaboratory
by: Mutaz Alkalbani, et al.
Published: (2024-01-01)

Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial
by: Michele Senni, et al.
Published: (2022-12-01)